GOF mutp53 can be obtained from TP53 variations that not only abolish the wild-type properties of p53, but also endow the mutant protein with new oncogenic activities [22], contributing to malignant progression and resistance to anti-cancer therapies [59,61,62]. Here, TP53 is linked to cancer.